Cancer Patient Guide
Prostate Cancer: Expert Insights for Treatment Decisions
Curated from 25 expert webinars (part of 150+ across all cancer types) hosted by Cancer Patient Lab, featuring oncologists from MD Anderson, University of Minnesota, and leading research centers. Real doctors. Real patient cases. Real treatment discussions.
Expert Panel
Oncologists and researchers who contributed insights through Cancer Patient Lab webinars
Oliver Sartor, MD
Radiopharmaceuticals, PSMA & lutetium therapy
Touro University
Emmanuel Antonarakis
Bipolar androgen therapy
University of Minnesota
Sumit Subudhi
Immunotherapy for metastatic prostate cancer
MD Anderson
Lisa Butterfield
Cancer vaccines for prostate cancer
Andrew Rech
CAR-T and immunotherapy developments
Mitchell Gross, MD, PhD
Drug repurposing for prostate cancer
Ally Perlina
Precision drug combinations
CureMatch
Ed Friedman
Hormone receptors and test interpretation
Chandra Kota, PhD
Radiation treatment navigation
Russ Hollyer
Self-experimentation with bipolar androgen therapy
Patient researcher
Saed Sayad
Drug repurposing strategies
Brian McCloskey
Comparative analysis across 10 patients
Cancer Patient Lab
Treatment Topics
Key treatment areas covered across our prostate cancer webinar series
Hormone Therapy & Androgen Deprivation
ADT remains the backbone of advanced prostate cancer treatment. Dr. Emmanuel Antonarakis discusses bipolar androgen therapy — cycling between high and low testosterone — as a strategy to destabilize cancer cells that have adapted to low-androgen environments. Ed Friedman explains how hormone receptor test results should guide therapy decisions.
Radiopharmaceuticals & PSMA-Targeted Therapy
Dr. Oliver Sartor — one of the leading researchers in prostate cancer radiopharmaceuticals — covers PSMA-targeted lutetium therapy (Pluvicto), which targets prostate cancer cells wherever they've spread. This is particularly relevant for patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed on other treatments.
Immunotherapy & CAR-T Cell Therapy
Prostate cancer has historically been resistant to immunotherapy. Dr. Sumit Subudhi from MD Anderson presents the latest approaches including combination strategies. Andrew Rech discusses emerging CAR-T cell therapy developments specifically designed for prostate cancer, including targeting PSMA and other prostate-specific antigens.
Genomic Testing & Precision Medicine
Molecular profiling is changing how prostate cancer is treated. Decipher and Prolaris tests help determine recurrence risk. FoundationOne CDx can identify actionable mutations like BRCA2 and ATM that qualify for PARP inhibitor therapy. Cancer Patient Lab's molecular tumor board reviews cases from multiple expert perspectives.
Making Treatment Decisions
Rick Stanton — a prostate cancer patient — shares how he navigated treatment decisions for advanced disease. Brian McCloskey compares test results and treatment strategies across 10 advanced prostate cancer patients, showing how similar diagnoses can lead to very different optimal treatment paths.
Common Questions from Prostate Cancer Patients
Answered by Navis AI, informed by expert webinars and medical guidelines
What does my Gleason score mean for treatment?
Should I choose active surveillance or immediate treatment?
What are the side effects of hormone therapy (ADT)?
How does BRCA2 mutation affect prostate cancer treatment?
What is PSMA-targeted therapy and am I eligible?
Should I get a Decipher or Prolaris genomic test?
What clinical trials are available for prostate cancer?
How do I appeal an insurance denial for prostate cancer treatment?
Testing Services for Prostate Cancer
Genomic testing, liquid biopsy, and molecular profiling services relevant to prostate cancer
All Prostate Cancer Webinars
From Cancer Patient Lab — a 501(c)(3) nonprofit
Prostate Cancer Radiopharmaceuticals: PSMA and Lutetium Treatment Updates
Oliver Sartor, MD
Bipolar Androgen Therapy for Prostate Cancer: How It Works
Emmanuel Antonarakis
Immunotherapy for Metastatic Prostate Cancer: Latest Treatment Updates
Sumit Subudhi
CAR-T and Immunotherapy for Prostate Cancer: Latest Developments
Andrew Rech
Metastatic Prostate Cancer Treatment: Current and Emerging Therapies
Oliver Sartor
Advanced Prostate Cancer: How to Make Treatment Decisions
Rick Stanton
Hormone Receptors in Prostate Cancer: What Your Test Results Mean
Ed Friedman
Molecular Tumor Board for Prostate Cancer: Getting Expert Multi-Specialist Review
Cancer Patient Lab Panel
Personalized Treatment for Advanced Prostate Cancer: Expert Case Review
Cancer Patient Lab Panel
Cancer Vaccines: How They Work and Who Can Benefit
Lisa Butterfield
Precision Cancer Drug Combinations: Targeting Multiple Pathways at Once
Ally Perlina, CureMatch
Drug Repurposing for Cancer: How Existing Drugs May Fight Tumors
Mitchell Gross, MD, PhD
Comprehensive Cancer Testing and Treatment Options Review
Robert Ellis
How One Patient Runs Self-Experiments with Bipolar Androgen Therapy
Russ Hollyer
Comparing Test Results and Treatment Strategies Across 10 Patients
Brian McCloskey
Treatment Options Review for Advanced Prostate Cancer
Mike Yancey
Navigating Radiation Treatments for Prostate Cancer
Chandra Kota, PhD
Prostate Cancer Treatment Roadmap: NCCN Guidelines Explained
Cancer Patient Lab Panel
Managing Osteoporosis During Prostate Cancer Treatment
Jeff Dwyer
Repurposing Approved Drugs for Prostate Cancer
Saed Sayad
Managing Hormone Therapy Side Effects with Exercise
Exercise Specialist
Get Personalized Prostate Cancer Insights
Upload your pathology report, genomic test, or lab results. Our AI translates them into plain English and matches you to relevant services and clinical trials.
This page is for informational purposes only and does not constitute medical advice. Content is curated from expert webinars hosted by Cancer Patient Lab, a 501(c)(3) nonprofit. Always consult your oncologist for treatment decisions.Meet our team →